415
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Reactions to tobacco warning labels: predictors and outcomes of adaptive and maladaptive responses

, &
Pages 383-393 | Received 20 Nov 2017, Accepted 28 Sep 2018, Published online: 22 Feb 2019
 

Abstract

Background: The Extended Parallel Process Model (EPPM) responses that emerge from spontaneous reactions to cigarette warning labels remain understudied. We identified the EPPM responses in reactions to cigarette warning labels and evaluated their predictors and relationship with warning perceptions.

Methods: U.S. adult current smokers, transitioning smokers (quit in the past two years or currently quitting) and never smokers (n = 1838) saw nine of 81 cigarette warning labels. Participants freely wrote their thoughts after viewing the first label and reported perceived informativeness, negative emotions, and denial for this label. Responses were coded for the presence of the EPPM response categories. Multivariable logistic regression models described adaptive and maladaptive respondent characteristics, and linear regression models assessed the relationship between the response categories and label perceptions.

Results: Participants’ responses contained adaptive (65.4%), maladaptive (16.5%), no response (14.7%), and mixed responses (both adaptive and maladaptive; 3.4%). Current smokers had decreased odds of adaptive response compared to never and transitioning smokers. Compared to text warnings, pictorial warnings were associated with increased odds of adaptive and decreased odds of maladaptive responses. Adaptive response was associated with increased odds of intentions to quit smoking. Adaptive respondents reported the highest levels of informativeness and negative emotions among the four response categories.

Conclusions: The finding demonstrating predominantly adaptive (and few maladaptive) responses to warning labels supports the continued use of fear appeals in warning label design. The greater adaptive and lower maladaptive responses to pictorial warnings could serve as additional evidence for FDA to implement pictorial warning labels.

Graphical Abstract

Acknowledgments

The authors wish to thank Jono Polansky of OnBeyond, LLC for helping with developing the labels.

Disclosure statement

The authors have no conflicts of interest.

Additional information

Funding

Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health and the Food and Drug Administration [R00CA187460]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.